Michaela commenced her role in 2024, having previously worked as Commercial Director of Specialty Care at J&J Innovative Medicine Austria.
In her new position, Michaela will lead the J&J Innovative Medicine commercial business in Ireland, with a focus on driving sustainable business growth by improving access to innovative therapies for the patients we serve.
Since joining the Austrian team in 2021, Michaela successfully led the Specialty Care Business, achieving consistent growth in immunology, central nervous system disorders, pulmonary hypertension and value optimisers / established brands portfolio, strengthening the business’s market position through a customer-centric strategy and talent development. She also played a crucial role in driving cultural development within the Austrian opco.
Prior to joining Johnson & Johnson, Michaela served as the Business Unit Director for the Oncology and Gastroenterology Unit at Takeda, where she oversaw a multi-country organisation.
Michaela is known for her dedication as a strong people-leader with an entrepreneurial mindset. Her unwavering focus and passion lie with patients, customers, and people. She has a proven track record of successfully leading teams in Austria, the Czech Republic and Slovakia.